Qidong Cai

898 total citations · 1 hit paper
25 papers, 638 citations indexed

About

Qidong Cai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qidong Cai has authored 25 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 17 papers in Cancer Research and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qidong Cai's work include RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (14 papers) and Ferroptosis and cancer prognosis (10 papers). Qidong Cai is often cited by papers focused on RNA modifications and cancer (16 papers), Cancer-related molecular mechanisms research (14 papers) and Ferroptosis and cancer prognosis (10 papers). Qidong Cai collaborates with scholars based in China and United States. Qidong Cai's co-authors include Xiang Wang, Boxue He, Zhenyu Zhao, Xiong Peng, Yongguang Tao, Pengfei Zhang, Hui Xie, Yuqian Zhang, Shuai Shi and Wei Yin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and The FASEB Journal.

In The Last Decade

Qidong Cai

25 papers receiving 631 citations

Hit Papers

miRNA-based biomarkers, therapies, and resistance in Cancer 2020 2026 2022 2024 2020 100 200 300 400

Peers

Qidong Cai
Boxue He China
Xuetao Li China
Huajie Bu Austria
Yuexin Hu China
Song Zhao China
Soonweng Cho United States
Boxue He China
Qidong Cai
Citations per year, relative to Qidong Cai Qidong Cai (= 1×) peers Boxue He

Countries citing papers authored by Qidong Cai

Since Specialization
Citations

This map shows the geographic impact of Qidong Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qidong Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qidong Cai more than expected).

Fields of papers citing papers by Qidong Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qidong Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qidong Cai. The network helps show where Qidong Cai may publish in the future.

Co-authorship network of co-authors of Qidong Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Qidong Cai. A scholar is included among the top collaborators of Qidong Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qidong Cai. Qidong Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Peng, Christopher Wang, Weilin Peng, et al.. (2025). The YTHDF3-DT/miR-301a-3p /INHBA axis attenuates autophagy-dependent ferroptosis in lung adenocarcinoma. Cancer Letters. 613. 217503–217503. 1 indexed citations
2.
Zhao, Zhenyu, Zhe Zhang, Qidong Cai, et al.. (2025). Lactylation increases the stability of RBM15 to drives m6A modification in non‐small‐cell lung cancer cells. The FASEB Journal. 39(6). e70493–e70493. 6 indexed citations
3.
Wang, Christopher, Qidong Cai, Muyun Peng, et al.. (2024). RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability. Life Sciences. 358. 123146–123146. 6 indexed citations
5.
Wang, Xuanye, et al.. (2024). Shared genetic aetiology of respiratory diseases: a genome-wide multitraits association analysis. BMJ Open Respiratory Research. 11(1). e002148–e002148. 2 indexed citations
6.
Li, Linfeng, Qidong Cai, Zeyu Wu, et al.. (2023). Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific Reports. 13(1). 2455–2455. 14 indexed citations
7.
Cai, Qidong, Boxue He, Weilin Peng, et al.. (2023). Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma. iScience. 26(7). 107013–107013. 5 indexed citations
8.
He, Boxue, Qidong Cai, Pengfei Zhang, et al.. (2022). Switched alternative splicing events as attractive features in lung squamous cell carcinoma. Cancer Cell International. 22(1). 5–5. 1 indexed citations
10.
Zhang, Pengfei, Boxue He, Qidong Cai, et al.. (2021). Decreased IL-6 and NK Cells in Early-Stage Lung Adenocarcinoma Presenting as Ground-Glass Opacity. Frontiers in Oncology. 11. 705888–705888. 4 indexed citations
11.
Zhao, Zhenyu, Qidong Cai, Pengfei Zhang, et al.. (2021). N6-Methyladenosine RNA Methylation Regulator-Related Alternative Splicing (AS) Gene Signature Predicts Non–Small Cell Lung Cancer Prognosis. Frontiers in Molecular Biosciences. 8. 657087–657087. 24 indexed citations
13.
Peng, Weilin, Qidong Cai, Zhenyu Zhao, et al.. (2021). Construction and validation of a 15-gene ferroptosis signature in lung adenocarcinoma. PeerJ. 9. e11687–e11687. 6 indexed citations
14.
Peng, Weilin, Qidong Cai, Zhenyu Zhao, et al.. (2021). A Novel Model Based on Genomic Instability-Associated Long Non-Coding RNAs for Predicting Prognosis and Response to Immunotherapy in Patients With Lung Adenocarcinoma. Frontiers in Genetics. 12. 720013–720013. 3 indexed citations
15.
Zhao, Zhenyu, Boxue He, Qidong Cai, et al.. (2021). Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma. International Immunopharmacology. 98. 107807–107807. 17 indexed citations
16.
He, Boxue, Pengfei Zhang, Qidong Cai, et al.. (2020). The top 100 most cited articles on bronchoscopy: a bibliometric analysis. BMC Pulmonary Medicine. 20(1). 229–229. 4 indexed citations
17.
Cai, Qidong, Boxue He, Pengfei Zhang, et al.. (2020). Exploration of predictive and prognostic alternative splicing signatures in lung adenocarcinoma using machine learning methods. Journal of Translational Medicine. 18(1). 463–463. 13 indexed citations
18.
Zhao, Zhenyu, Boxue He, Qidong Cai, et al.. (2020). A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma. PeerJ. 8. e10008–e10008. 3 indexed citations
19.
He, Boxue, Zhenyu Zhao, Qidong Cai, et al.. (2020). miRNA-based biomarkers, therapies, and resistance in Cancer. International Journal of Biological Sciences. 16(14). 2628–2647. 436 indexed citations breakdown →
20.
Cai, Qidong, Pengfei Zhang, Boxue He, et al.. (2020). Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma. Cancer Genetics. 246-247. 1–11. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026